As a tumor-suppressor factor, lncRNA DRAIC inhibits capacity of IKK complex in phosphorylating IκBα, resulting in NF-κB signaling inhibition and decreased progression of prostate cancer cells [237]. The gene discussed is NFKB1; the disease is neoplasm.